AlphaGenome: DeepMind's AI Maps 9 Billion Human SNV Functional Impacts
DeepMind's AlphaGenome uses a 1Mb-context deep learning model with sparse attention to predict functional impacts for ~9 billion human SNVs, integrating multi-task epigenomic predictions to aid clinical variant interpretation while acknowledging limitations in non-coding validation and population bias.
